×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RLAY – relay therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RLAY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
01:37 pm
rlay
Relay Therapeutics (RLAY) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Medium
Report
Relay Therapeutics (RLAY) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
12/12
09:34 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock.
Medium
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock.
12/11
06:17 am
rlay
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival [Yahoo! Finance]
Medium
Report
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival [Yahoo! Finance]
12/11
06:00 am
rlay
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
High
Report
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
12/9
04:10 pm
rlay
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Medium
Report
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium [Yahoo! Finance]
12/9
04:05 pm
rlay
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium
Medium
Report
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium
12/5
08:02 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target lowered by analysts at Leerink Partners from $19.00 to $18.00. They now have an "outperform" rating on the stock.
Medium
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target lowered by analysts at Leerink Partners from $19.00 to $18.00. They now have an "outperform" rating on the stock.
12/4
08:09 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target lowered by analysts at HC Wainwright from $20.00 to $16.00. They now have a "buy" rating on the stock.
Neutral
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target lowered by analysts at HC Wainwright from $20.00 to $16.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
12/12
09:34 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Medium
Report
-3.8%
12/12
09:34 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Medium
Report
-3.8%
12/12
09:25 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Medium
Report
-4.4%
12/12
09:25 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Medium
Report
-4.4%
Date
Time
Symbol
Headline
Impact
12/18
04:52 pm
rlay
Form 4 Relay Therapeutics, Inc. For: Dec 16 Filed by: Patel Sanjiv
Low
Report
Form 4 Relay Therapeutics, Inc. For: Dec 16 Filed by: Patel Sanjiv
12/16
04:19 pm
rlay
Form 144 Relay Therapeutics, Inc. Filed by: Patel Sanjiv
Medium
Report
Form 144 Relay Therapeutics, Inc. Filed by: Patel Sanjiv
12/11
07:01 am
rlay
Form 8-K Relay Therapeutics, Inc. For: Dec 11
Medium
Report
Form 8-K Relay Therapeutics, Inc. For: Dec 11
11/14
01:24 pm
rlay
Form SC 13G/A Relay Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SC 13G/A Relay Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/6
04:16 pm
rlay
Form 10-Q Relay Therapeutics, Inc. For: Sep 30
Low
Report
Form 10-Q Relay Therapeutics, Inc. For: Sep 30
11/6
04:10 pm
rlay
Form 8-K Relay Therapeutics, Inc. For: Nov 06
Low
Report
Form 8-K Relay Therapeutics, Inc. For: Nov 06
10/30
04:10 pm
rlay
Form 4 Relay Therapeutics, Inc. For: Oct 28 Filed by: Rahmer Peter
Low
Report
Form 4 Relay Therapeutics, Inc. For: Oct 28 Filed by: Rahmer Peter
10/30
04:09 pm
rlay
Form 4 Relay Therapeutics, Inc. For: Oct 28 Filed by: Bergstrom Donald A
Low
Report
Form 4 Relay Therapeutics, Inc. For: Oct 28 Filed by: Bergstrom Donald A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: